A Phase I Dose Escalation Study of RAD001 in Combination With Chemotherapy and Radiation in Patients With NSCLC.
Phase of Trial: Phase I
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Cisplatin; Everolimus; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 03 Jul 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 03 Jul 2012 Actual patient number is 3 according to ClinicalTrials.gov.
- 03 Jul 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.